Venous thromboembolism (VTE) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) - underlying prothrombotic condition in active disease?

被引：0
|
作者：
Antovic, A. [1 ]
Svensson, E. [1 ]
Borjesson, O. [1 ]
Bruchfeld, A. [2 ]
Gunnarsson, I. [1 ]
机构：
[1] Karolinska Univ Hosp, Dept Med, Rheumatol Unit, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Renal Med, Stockholm, Sweden
来源：
THROMBOSIS RESEARCH | 2017年 / 151卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-030
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
    Cheng, L.
    Gou, S. -J.
    Qiu, H. -Y.
    Ma, L.
    Fu, P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (01): : 116 - 124
  • [22] ORGAN DAMAGE AND HOSPITALIZATION IN ELDERLY PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS
    Weiner, Maria
    Goh, Su Mein
    Mohammad, Aladdin J.
    Hruskova, Zdenka
    Tanna, Anisha
    Sharp, Phoebe
    Kang, Amy
    Bruchfeld, Annette
    Selga, Daina
    Chocova, Zdenka
    Westman, Kerstin
    Eriksson, Per
    Harper, Lorraine
    Pusey, Charles D.
    Tesar, Vladimir
    Salama, Alan D.
    Segelmark, Marten
    RHEUMATOLOGY, 2017, 56 : 32 - 32
  • [23] Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis
    Savage, C. O. S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 23 - 26
  • [24] Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management
    Plumb, Lucy A.
    Oni, Louise
    Marks, Stephen D.
    Tullus, Kjell
    PEDIATRIC NEPHROLOGY, 2018, 33 (01) : 25 - 39
  • [25] Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management
    Lucy A Plumb
    Louise Oni
    Stephen D Marks
    Kjell Tullus
    Pediatric Nephrology, 2018, 33 : 25 - 39
  • [26] Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis
    Gencik, M
    Borgmann, S
    Zahn, R
    Albert, E
    Sitter, T
    Epplen, JT
    Fricke, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 117 (02): : 412 - 417
  • [27] Fatal haemorrhagic varicella in a patient with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
    Ben-Chetrit, E.
    Lachish, T.
    Nesher, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (01) : S95 - S95
  • [28] Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis
    Thickett, DR
    Richter, AG
    Nathani, N
    Perkins, GD
    Harper, L
    RHEUMATOLOGY, 2006, 45 (03) : 261 - 268
  • [29] Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis
    Niles, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 27 - 30
  • [30] Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type
    Unizony, Sebastian
    Villarreal, Miguel
    Miloslavsky, Eli M.
    Lu, Na
    Merkel, Peter A.
    Spiera, Robert
    Seo, Philip
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, C. G. M.
    St Clair, E. William
    Ikle, David
    Tchao, Nadia K.
    Ding, Linna
    Brunetta, Paul
    Choi, Hyon K.
    Monach, Paul A.
    Fervenza, Fernando
    Stone, John H.
    Specks, Ulrich
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (06) : 1166 - 1169
12345